Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-06

Clinical Trial Update: Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated intrathyroid injections of dexamethasone to prevent relapse in Graves' disease, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Xiao-Ming Mao | Conditions: Graves' Disease | Phase 4 | Status: COMPLETED